How chromatin domains are established and maintained in higher eukaryotes are poorly understood, especially during development. Covalent modifications of histones carry significant amount of information that complement to genetic information in dictating developmental process. Mutations in histone modifying enzymes are commonly found in human diseases, further underlying their fundamental roles in cells. One such enzyme is MLL1 (mixed lineage leukemia), which is evolutionarily conserved and promotes 5'Hox gene transcription. MLL1 is a histone methyltransferase for H3 lysine 4, a mark highly enriched at gene promoters and enhancers. Studies have found that MLL1 plays important roles in normal and malignant hematopoiesis. Knockout MLL1 gene leads to profound defects in hematopoietic stem cells compartment and blocks MLL1 fusion protein mediated leukemogenesis. Despite these findings, the obligatory function of H3 K4 methylation in MLL1 dependent biological pathways remains unclear. Our biochemical studies have revealed that the MLL1 methyltransferase activity is tightly regulated by three proteins including WDR5, RbBP5 and ASH2L. We, and others, further demonstrate that MLL1-WDR5 interaction is essential for complex integrity. Blocking this interaction abolishes MLL1 activity. Based on these results, we have developed a highly specific chemical probe that targets MLL1 methyltransferase activity by disrupting MLL1 complex assembly. Using this novel probe, we will directly address the function of MLL1 mediated H3 K4 methylation in malignant process (without affecting other MLL1 functions). This novel probe also, for the first time, allows us to examine the dynamic and reversible functions of H3K4 methylation during normal cell differentiation. Our studies will have high impact in the chromatin field and translational research.
Mixed lineage leukemia (MLL) is a form of cancer in which the normal development of blood cells is blocked and the cells abnormally proliferate. Mutations in MLL gene associate with ~10% AML and ALL cases in both children and adults. The goal of work is to understand the fundamental mechanism of MLL1-mediated transcription regulation and other cellular processes. Our studies will lay foundations for developing further therapeutics.
|Zhou, Bo; Wang, Jingya; Lee, Shirley Y et al. (2016) PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity. Mol Cell :|
|Zhang, Hui; Gayen, Srimonta; Xiong, Jie et al. (2016) MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency. Cell Stem Cell 18:481-94|
|Xu, Jing; Li, Li; Xiong, Jie et al. (2016) MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program. Cell Discov 2:16008|
|Wang, Weimin; Kryczek, Ilona; DostÃ¡l, LubomÃr et al. (2016) Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer. Cell 165:1092-105|
|Li, Yanjing; Han, Jianming; Zhang, Yuebin et al. (2016) Structural basis for activity regulation of MLL family methyltransferases. Nature 530:447-52|
|Rao, Rajesh C; Dou, Yali (2015) Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 15:334-46|
|Peng, Dongjun; Kryczek, Ilona; Nagarsheth, Nisha et al. (2015) Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature 527:249-53|
|Lee, Young-Tae; Gibbons, Garrett; Lee, Shirley Y et al. (2015) One-pot refolding of core histones from bacterial inclusion bodies allows rapid reconstitution of histone octamer. Protein Expr Purif 110:89-94|
|Su, Xiaonan; Zhu, Guixin; Ding, Xiaozhe et al. (2014) Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin/Ssty repeats of Spindlin1. Genes Dev 28:622-36|
|Wu, Lipeng; Li, Li; Zhou, Bo et al. (2014) H2B ubiquitylation promotes RNA Pol II processivity via PAF1 and pTEFb. Mol Cell 54:920-31|
Showing the most recent 10 out of 19 publications